(Total Views: 398)
Posted On: 09/18/2019 12:15:43 PM
Post# of 36
$PULM News Article - Pulmatrix and Cipla Announce First Patient Dosed in Phase 2 Trial Evaluating Pulmazole for Treatment of Allergic Bronchopulmonary Aspergillosis in Patients with Asthma https://marketwirenews.com/news-releases/pulm...75727.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼